Screening form for participation in the ENCORE trial

Thank you for your interest in the ENCORE trial!

The clinical reporting form (CRF) consists of a limited amount of data regarding anesthesia, surgery and oncological treatment of patients with colon cancer. The following information regarding institutional volume and follow-up are required to assess eligibility of your study site.

Question Title

* 1. 1. Regarding the Hospital

Country

City

Name of Hospital

Type of Hospital (University/Academic, Regional, Local)

Question Title

* 2. Contact

Name of the person completing the survey (Preferably Principal Investigator)

Email address of the person completing the survey (for clarification of responses only)

Question Title

* 3. Does your hospital treat more than 50 patients with colon cancer per year?

Yes

Question Title

* 4. Will you be able to report postoperative adverse events (postoperative complications) according to the Clavien-Dindo classification within 30 days after surgery?

Yes

Question Title

* 5. Will you be able to report the date of return to original residency after recovery from surgery ?

Yes

Question Title

* 6. Will you or your colleagues be able to report surgical outcomes (recurrence, death etc) after 3 years?

Yes

Question Title

* 7. Preferred anesthetic technique for colo-rectal cancer surgery (with or without epidural)

Inhalational anesthesia

Total intravenous anesthesia

Question Title

* 8. Are Epidurals commonly used for open surgery for colorectal cancer ?

Yes

Question Title

* 9. Are neuraxial blocks (spinal or epidural) commonly used for laparoscopic/robot colorectal cancer surgery?

Yes

Question Title

* 10. Do you have a ERAS program (Enhanced Recovery After Surgery) ?

Yes

Question Title

* 11. Do you have a Prehabilitation program (improving cardiorespiratory function before surgery ?

Yes

Question Title

* 12. Do you use cardiopulmonary exercise testing (CPET) for risk stratification ?

Yes

Question Title

* 13. What OTHER risk stratification tool do you use?

Question Title

* 14. Regarding your participation: Are you willing to be the Primary Investigator (PI) from your site?

Yes

Question Title

* 15. Regarding your participation : Would you like to be the National coordinator (NC) for your country?

Yes

Question Title

* 16. Do you recommend another institution/ hospital/ colleague to contact for participation in the ENCORE Study ? If yes, please provide their contact details.